Featured Courses

Lifting the Burden: Customizing Treatment for Patients with Headache Disorders | myCME

AMA PRA Category 1 Credit(s)^TM

This interactive program differentiates burden and presentation of a migraine and cluster headache disorder. Faculty experts will share analysis of the latest trial data on acute and preventative therapies to inform your clinical practice.

Clinical Paths in the Preventive Treatment of Migraine | myCME

AMA PRA Category 1 Credit(s)^TM

This online, case-based activity explores advances and challenges in the care of patients with migraine from diagnosis through treatment. Topics discussed include strategies for differential diagnosis, recognition of medication overuse, and criteria for use of preventive therapy. In addition, our expert faculty describes advances in the understanding of migraine pathophysiology that have led to new treatments and reviews key clinical data to inform the appropriate use of these therapies.

Getting Ahead of Migraine: Best Practices for Migraine Prevention—Migraine Diagnosis and Burden of Disease | myCME

AMA PRA Category 1 Credit(s)^TM

“My migraines made me feel like I was a part-time parent. They were so bad that my husband and I came to the difficult decision that we could not have more kids because I could not function as a parent ‒ I could barely function as an adult.” Do you know how migraine affects the daily lives of your patients? Join Dr Cynthia Armand and Dr Carrie Dougherty to learn more about caring for patients with this debilitating disease

Getting Ahead of Migraine: Best Practices for Migraine Prevention—Targeting CGRP for Migraine Prevention | myCME

AMA PRA Category 1 Credit(s)^TM

Four anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies are approved for migraine prevention. To ensure clinicians are prepared to consider these agents when clinically indicated, this educational activity will compare the efficacy and safety of these therapies for migraine prevention and discuss strategies for shared decision-making.

Unmet Needs and the Evolving Landscape in Acute Treatment of Migraine: Primary Care Professionals on the Front Line | myCME

AMA PRA Category 1 Credit(s)^TM, AAFP Prescribed Credit

Novel targeted therapies for the acute treatment of migraine—5-HT1F and CGRP receptor agonists—lack the CV contraindications of older migraine medications.

Diagnosis, Treatment and Prevention Therapies in Primary Headache Disorders | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists

Distinguishing a primary from a secondary headache disorder, as well as among primary headache disorders, is often challenging. Focusing on cluster and migraine, Drs. Jessica Ailani and Stewart Tepper provide criteria and strategies to overcome this challenge in the office setting.

Setting Goals and Expectations With CGRPs for Migraine Prevention

AMA PRA Category 1 Credit(s)^TM

Join an expert faculty panel as they discuss incorporating anti-CGRP monoclonal antibodies into daily clinical practice for migraine prevention. This video-based session will integrate didactic presentation, a case-based panel discussion, and expert review of clinical evidence, guideline recommendations, special considerations, and real-world use.

The Emerging Role of CGRP Inhibitors in the Prevention and Treatment of Migraine

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists, AANP Contact Hour(s), ABIM MOC Credit

The emergence of four monoclonal antibodies or therapies targeting calcitonin gene-related peptide (CGRP) has transformed the treatment of migraine. This presentation reviews the discovery of this drug class, analyzes data from clinical trials, discusses future therapies in the class, and highlights clinical pearls to help attendees better understand these therapies and integrate them into clinical practice.

Challenges and Advances in the Diagnosis and Treatment of Migraine

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CE for Pharmacists, AANP Contact Hour(s), ABIM MOC Credit

Migraine¬—the 2nd most disabling disease worldwide with an estimated global prevalence of approximately 15%, or 1 in 7 people—is more prevalent than diabetes, epilepsy, and asthma combined.

SCOPE of Pain: Podcast Training | myCME

AMA PRA Category 1 Credit(s)^TM, AAFP Prescribed Credit, CNE Contact Hour(s), ABIM MOC Credit

SCOPE of Pain: Podcast Training

A Migraine Toolbox- Module 3: Specialty Care | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CDE Credit, CE for Pharmacists

This educational module addresses specialized topics of migraine management. By its conclusion, you should be confident that you have the skills to recognize and treat pediatric headaches and other disorders, to choose the most effective emergent migraine care and to perform nerve blocks.

A Migraine Toolbox: A Practical Approach to Diagnosis and Treatment – Module 4: Specialty Care | myCME

AMA PRA Category 1 Credit(s)^TM, CNE Contact Hour(s), CDE Credit, CE for Pharmacists

This module addresses more specialized topics in migraine care.